Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010452 · ClinicalTrials.gov registry record · Phase 2
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
A Phase 2 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00010452 is a Phase 2 study that has completed, run by University of Iowa. The registered enrollment target is 150 participants.
The verdict
NCT00010452, a Phase 2 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.
Interventions
- DRUG picibanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2000-04 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010452
The ClinicalTrials.gov registry entry for NCT00010452 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which picibanil is the first listed.
NCT00010452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00010452 about?
NCT00010452 is a clinical study titled "Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations". OBJECTIVES: I. Determine the efficacy of picibanil sclerotherapy in children with macrocystic lymphangioma.
What is the current status of trial NCT00010452?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2000-04. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00010452?
The interventions under investigation include: picibanil (DRUG).
Who is sponsoring clinical trial NCT00010452?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.